Evidence map›Paper›PMID 42164952›Full record

ArticleBrain communications2026

An 18-fluorodeoxyglucose-PET study in

Elze R Timmers, Henriëtte C J Dijkhuis, Ramesh S Marapin, Bauke M de Jong, Débora E Peretti, Jelle R Dalenberg, Marina A J Tijssen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elze R TimmersDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.
Henriëtte C J DijkhuisDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.ORCID https://orcid.org/0009-0006-4014-1854
Ramesh S MarapinDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.
Bauke M de JongDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.ORCID https://orcid.org/0000-0002-6568-5739
Débora E PerettiClinical Neuroimaging HUG, Hopitaux Universitaires de Genève, 1211 Genève, Switzerland.ORCID https://orcid.org/0000-0002-3033-8817
Jelle R DalenbergExpertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), Groningen, Groningen 9713 GZ, The Netherlands.ORCID https://orcid.org/0000-0001-8580-5358
Marina A J TijssenDepartment of Neurology, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, the Netherlands.ORCID https://orcid.org/0000-0001-5783-571X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myoclonus-dystonia is a hyperkinetic movement disorder, and approximately half of myoclonus-dystonia patients have a mutation in the

Indexed as

[18F]FDG-PETglucose metabolismmyoclonus-dystonia

Identifiers

PMID42164952
PMCPMC13184688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.